Recent News

A recent study by Carvalho et al., titled “Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients” explores the potential use of at-home tDCS for treating fibromyalgia.

In patients with major depressive disorder (MDD), abnormal, elevated oscillating activity of the alpha frequency brain waves have been observed—mostly located in the left frontal regions of the brain. This increased alpha oscillation strength in depressed patients have been correlated with a state of low neuronal activity

A recent article on psychiatryadvisor.com gives an overview of the role of tDCS in treating depression in pregnant patients—depression being one of the most common psychiatric disorder experienced during pregnancy.

Soterix Medical Inc. has recently been awarded a contract by the National Institute of Drug Abuse (NIDA) and National Institutes of Health (NIH) for a Phase I clinical trial of their portable self-administered tDCS device for the treatment of cocaine addiction.

A recent study published by Dr. Leigh Charvet and colleagues at NYU Langone Health explored the use of tDCS intervention for Parkinson's disease in a home setting with remote supervision from technicians.

Schizophrenia is a debilitating mental disorder characterized by symptoms divided into two categories: positive symptoms-- which correspond with psychotic behaviors present in schizophrenic patients not seen in healthy people-- and negative symptoms-- referring to missing characteristics of emotion and behavior normally seen in healthy people.

A recent article posted on artsy.com -- a well known worldwide hub for the arts -- talks about the current use and implications of transcranial electrical stimulation (tES) for creativity. The article brings up how tES is being explored to modulate concentration, vigilance, fatigue, motor coordination and performance.

Looking to obtain hands-on training and a certification for tDCS? From October 22nd to 25th, the Center for Discovery and Innovation in Manhattan, NY will be hosting the NYC tDCS Fellowship 2018. The four day program is designed to provide an in depth theoretical background and practical hands-on experience toward tDCS protocol design and application.

It’s happening soon! On August 23 to 26th, neuromodulation researchers and professionals across the world will be at the Sheraton Hotel in Times Square, NYC to unveil the most state of the art in neuromodulation technology.

A recent study released earlier this month by researchers at University of Pennsylvania suggests transcranial direct current stimulation (tDCS) can be used to reduce aggressive behavior linked to the likelihood of physical and sexual assault, and even increase the likelihood of the user to judge aggressive acts morally wrongful.